Qube Research & Technologies LTD Immunocore Holdings PLC Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 23,015 shares of IMCR stock, worth $681,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,015
Previous 191,541
87.98%
Holding current value
$681,244
Previous $5.96 Million
88.63%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding IMCR
# of Institutions
124Shares Held
42.3MCall Options Held
140KPut Options Held
207K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$198 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$196 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$144 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$79 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$64.8 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.3B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...